Deep Learning Identifies PPMS Patients Who May Respond to Treatment
(MedPage Today) -- Deep learning identified subgroups of patients with primary progressive multiple sclerosis (PPMS) who may respond to disease-modifying therapy, researchers said.
A trained model separated responders and non-responders across...
Read more »